Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2026-05-22 @ 11:55 PM
Study NCT ID:
NCT05002569
Status:
TERMINATED
Last Update Posted:
2025-05-18
First Post:
2021-08-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma
Sponsor:
Bristol-Myers Squibb
Organization: